Eli Lilly’s rare 40-year bond sparks talk of a Viking Therapeutics (VKTX) acquisition. Experts say LLY is “setting up for something BIG.”
Eli Lilly’s rare 40-year bond sparks talk of a Viking Therapeutics (VKTX) acquisition. Experts say LLY is “setting up for something BIG.”